Add as a preferred source on GoogleSBC Medical Group Sees Longevity Plans Adding Revenue Around 2028
Management expects AI efforts, operating leverage and MSO scale to support further EBITDA margin gains. The company may open branded U.S. clinics within six to 12 months.
SBC Medical Group Holdings Incorporated management expects the company’s longevity initiatives to make a meaningful revenue contribution around 2028, while it sees further room to improve EBITDA margins.
The roadmap includes biomarker testing, a center and a platform. Management expects AI efforts, operating leverage and MSO scale to support further margin gains.
Management expects growth over the medium and long term, though it may vary in the short term. SBC may open branded clinics in the United States within six to 12 months.
The company is prioritizing acquisitions and new clinic openings. Management is not considering additional share buybacks at this time and plans to fund the initiatives with operating cash flow and net cash it describes as ample.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.